tiprankstipranks
Prestige Consumer Healthcare (DE:PBV)
FRANKFURT:PBV
Germany Market

Prestige Consumer Healthcare (PBV) Ratios

0 Followers

Prestige Consumer Healthcare Ratios

DE:PBV's free cash flow for Q1 2027 was $0.51. For the 2027 fiscal year, DE:PBV's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
3.23 3.57 4.20 3.20 2.44
Quick Ratio
1.99 2.25 2.82 2.02 1.43
Cash Ratio
0.58 0.53 0.92 0.40 0.36
Solvency Ratio
0.08 0.13 0.16 0.14 -0.03
Operating Cash Flow Ratio
1.62 2.13 2.36 2.13 1.43
Short-Term Operating Cash Flow Coverage
23.87 86.28 0.00 0.00 0.00
Net Current Asset Value
$ -2.16B$ -1.23B$ -1.12B$ -1.29B$ -1.51B
Leverage Ratios
Debt-to-Assets Ratio
0.45 0.29 0.31 0.34 0.41
Debt-to-Equity Ratio
1.08 0.55 0.57 0.69 0.94
Debt-to-Capital Ratio
0.52 0.36 0.36 0.41 0.49
Long-Term Debt-to-Capital Ratio
0.51 0.34 0.35 0.40 0.48
Financial Leverage Ratio
2.38 1.88 1.85 2.00 2.32
Debt Service Coverage Ratio
4.43 5.82 6.14 4.57 0.28
Interest Coverage Ratio
6.30 7.31 7.07 5.10 -0.32
Debt to Market Cap
0.91 0.35 0.23 0.32 0.43
Interest Debt Per Share
44.45 22.45 21.97 24.25 28.79
Net Debt to EBITDA
6.31 2.96 2.61 2.92 166.19
Profitability Margins
Gross Profit Margin
53.26%52.78%55.76%55.49%55.45%
EBIT Margin
25.37%27.54%29.16%30.50%-2.19%
EBITDA Margin
28.30%30.41%31.82%33.22%0.70%
Operating Profit Margin
26.26%28.42%29.60%30.43%-1.99%
Pretax Profit Margin
21.20%23.65%24.98%24.53%-8.33%
Net Profit Margin
15.57%17.48%18.86%18.60%-7.30%
Continuous Operations Profit Margin
15.57%17.48%18.86%18.60%-7.30%
Net Income Per EBT
73.43%73.90%75.51%75.84%87.64%
EBT Per EBIT
80.73%83.22%84.39%80.61%418.98%
Return on Assets (ROA)
3.77%5.36%6.31%6.31%-2.45%
Return on Equity (ROE)
9.22%10.08%11.70%12.65%-5.69%
Return on Capital Employed (ROCE)
6.57%9.03%10.22%10.70%-0.70%
Return on Invested Capital (ROIC)
4.80%6.65%7.70%8.10%-0.61%
Return on Tangible Assets
25.51%28.54%37.04%44.53%-17.00%
Earnings Yield
7.72%6.63%5.02%5.87%-2.63%
Efficiency Ratios
Receivables Turnover
5.90 5.67 5.86 6.37 6.75
Payables Turnover
14.01 22.56 26.59 12.85 8.01
Inventory Turnover
2.71 3.23 3.41 3.61 3.10
Fixed Asset Turnover
6.73 6.36 8.90 12.60 12.60
Asset Turnover
0.24 0.31 0.33 0.34 0.34
Working Capital Turnover Ratio
3.38 3.34 3.79 4.60 5.92
Cash Conversion Cycle
170.30 161.15 155.73 130.01 126.25
Days of Sales Outstanding
61.89 64.34 62.33 57.34 54.06
Days of Inventory Outstanding
134.45 112.99 107.12 101.08 117.78
Days of Payables Outstanding
26.05 16.18 13.72 28.40 45.58
Operating Cycle
196.34 177.33 169.45 158.42 171.83
Cash Flow Ratios
Operating Cash Flow Per Share
5.25 5.32 5.06 5.00 4.61
Free Cash Flow Per Share
4.96 5.09 4.90 4.81 4.45
CapEx Per Share
0.30 0.23 0.17 0.19 0.16
Free Cash Flow to Operating Cash Flow
0.94 0.96 0.97 0.96 0.97
Dividend Paid and CapEx Coverage Ratio
17.76 23.05 30.58 26.07 29.51
Capital Expenditure Coverage Ratio
17.76 23.05 30.58 26.07 29.51
Operating Cash Flow Coverage Ratio
0.12 0.25 0.24 0.22 0.17
Operating Cash Flow to Sales Ratio
0.23 0.24 0.22 0.22 0.20
Free Cash Flow Yield
10.58%8.58%5.69%6.71%7.10%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
13.08 15.08 19.90 17.04 -37.96
Price-to-Sales (P/S) Ratio
2.01 2.64 3.76 3.17 2.77
Price-to-Book (P/B) Ratio
1.16 1.52 2.33 2.15 2.16
Price-to-Free Cash Flow (P/FCF) Ratio
9.45 11.65 17.56 14.90 14.08
Price-to-Operating Cash Flow Ratio
8.93 11.15 16.99 14.33 13.60
Price-to-Earnings Growth (PEG) Ratio
-0.79 -1.67 7.62 -0.05 0.27
Price-to-Fair Value
1.16 1.52 2.33 2.15 2.16
Enterprise Value Multiple
13.43 11.64 14.42 12.46 562.96
Enterprise Value
4.20B 3.85B 5.22B 4.66B 4.43B
EV to EBITDA
13.43 11.64 14.42 12.46 562.96
EV to Sales
3.80 3.54 4.59 4.14 3.93
EV to Free Cash Flow
17.84 15.64 21.45 19.47 19.97
EV to Operating Cash Flow
16.84 14.96 20.75 18.72 19.30
Tangible Book Value Per Share
-41.66 -20.50 -19.88 -23.98 -28.51
Shareholders’ Equity Per Share
40.38 38.95 36.92 33.26 29.01
Tax and Other Ratios
Effective Tax Rate
0.27 0.26 0.24 0.24 0.12
Revenue Per Share
23.28 22.47 22.89 22.62 22.61
Net Income Per Share
3.62 3.93 4.32 4.21 -1.65
Tax Burden
0.73 0.74 0.76 0.76 0.88
Interest Burden
0.84 0.86 0.86 0.80 3.79
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.25 0.24 0.23 0.09 0.10
Stock-Based Compensation to Revenue
0.01 <0.01 <0.01 0.01 0.01
Income Quality
1.45 1.35 1.17 1.19 -2.79
Currency in USD